White Adipose Tissue Autophagy and Adipose-Liver Crosstalk Exacerbate Nonalcoholic Fatty Liver Disease in MiceSummary

par Sadatsugu Sakane, Hayato Hikita, Kumiko Shirai, Yuta Myojin, Youichi Sasaki, Shinnosuke Kudo, Kenji Fukumoto, Naoki Mizutani, Yuki Tahata, Yuki Makino, Ryoko Yamada, Takahiro Kodama, Ryotaro Sakamori, Tomohide Tatsumi, Tetsuo Takehara
Publié 2021

A nomogram for predicting metabolic steatohepatitis: The combination of NAMPT, RALGDS, GADD45B, FOSL2, RTP3, and RASD1

par Liao Shenling, He He, Zeng Yuping, Yang Lidan, Liu Zhi, An Zhenmei, Zhang Mei
Publié 2021

Endotoxin Producers Overgrowing in Human Gut Microbiota as the Causative Agents for Nonalcoholic Fatty Liver Disease

par Na Fei, Aurélia Bruneau, Xiaojun Zhang, Ruirui Wang, Jinxing Wang, Sylvie Rabot, Philippe Gérard, Liping Zhao
Publié 2020

Novel insights into the relationship between nonalcoholic fatty liver disease and osteoporosis

par Filip R, Radzki RP, Bieńko M
Publié 2018

Farnesoid X receptor (FXR) as a potential therapeutic target in nonalcoholic fatty liver disease and associated syndromes

par Apollinariya V. Bogolyubova, Alexander Y. Mayorov, Ekaterina E. Mishina, Anton M. Schwartz, Pavel V. Belousov
Publié 2017

Activated Natural Killer Cell Promotes Nonalcoholic Steatohepatitis Through Mediating JAK/STAT PathwaySummary

par Feixue Wang, Xiang Zhang, Weixin Liu, Yunfei Zhou, Wenchao Wei, Dabin Liu, Chi Chun Wong, Joseph J.Y. Sung, Jun Yu
Publié 2022

Association between Equol Production Status and Nonalcoholic Steatohepatitis

par Takemi Akahane, Daisuke Kaya, Ryuichi Noguchi, Kosuke Kaji, Haruna Miyakawa, Yukihisa Fujinaga, Yuki Tsuji, Hiroaki Takaya, Yasuhiko Sawada, Masanori Furukawa, Koh Kitagawa, Takahiro Ozutsumi, Hideto Kawaratani, Kei Moriya, Tadashi Namisaki, Hitoshi Yoshiji
Publié 2021

First‐line sorafenib sequential therapy and liver disease etiology for unresectable hepatocellular carcinoma using inverse probability weighting: A multicenter retrospective study...

par Shigeo Shimose, Atsushi Hiraoka, Masahito Nakano, Hideki Iwamoto, Masatoshi Tanaka, Takaaki Tanaka, Kazunori Noguchi, Hajime Aino, Kei Ogata, Masahiko Kajiwara, Satoshi Itano, Yoshinori Yokokura, Taizo Yamaguchi, Hiroshi Kawano, Norito Matsukuma, Hideya Suga, Takashi Niizeki, Tomotake Shirono, Yu Noda, Naoki Kamachi, Shusuke Okamura, Takumi Kawaguchi, Hironori Koga, Takuji Torimura
Publié 2021

Novel Application of the Traditional Lipid Ratios as Strong Risk Predictors of NASH

par Hegazy M, Saleh SA, Ezzat A, Behiry ME
Publié 2020

Ileal Bile Acid Transporter Inhibitor Improves Hepatic Steatosis by Ameliorating Gut Microbiota Dysbiosis in NAFLD Model Mice

par Masahiro Matsui, Shinya Fukunishi, Takashi Nakano, Takaaki Ueno, Kazuhide Higuchi, Akira Asai
Publié 2021

Nonalcoholic fatty liver disease: cause or consequence of insulin resistance?

par Ekaterina E. Mishina, Alexander Y. Mayorov, Pavel O. Bogomolov, Maria V. Matsievich, Ksenia Y. Kokina, Apollinariya V. Bogolyubova
Publié 2017

Association of insulin resistance and non-alcoholic fatty liver disease

par Ekaterina E. Mishina, Alexander Y. Mayorov, Pavel O. Bogomolov, Ekaterina O. Liusina, Alexey O. Bueverov
Publié 2021

EXPRESSION OF TLR2, TLR3, TLR4 AND PROINFLAMMATORY TNF AND IL-6 CYTOKINES IN LIVER BIOPSIES OF NONALCOHOLIC FATTY LIVER DISEASE PATIENTS

par A. V. Bogolyubova, E. E. Mishina, P. O. Bogomolov, M. V. Matsievich, K. Yu. Kokina, A. Yu. Mayorov, P. V. Belousov
Publié 2019

Risk factors of nonalcoholic fatty liver disease in lean body mass population: A systematic review and meta‐analysis

par Shahinul Alam, Mohammad Eslam, Nazmul SKMHasan, Kamrul Anam, Muhammad Abdul Baker Chowdhury, Md Abdullah Saeed Khan, Mohammad J Hasan, Rosmawati Mohamed
Publié 2021

Effects of duodenal–jejunal bypass surgery in ameliorating nonalcoholic steatohepatitis in diet-induced obese rats

par Yu HH, Hsieh MC, Wu SY, Sy ED, Shan YS
Publié 2019

Cholesterol Metabolism: A Double-Edged Sword in Hepatocellular Carcinoma

par Fangli Zhou, Xiaoli Sun
Publié 2021

PNPLA3 genotype and fibrosis-4 index predict cardiovascular diseases of Japanese patients with histopathologically-confirmed NAFLD

par Norio Akuta, Yusuke Kawamura, Yasuji Arase, Satoshi Saitoh, Shunichiro Fujiyama, Hitomi Sezaki, Tetsuya Hosaka, Masahiro Kobayashi, Mariko Kobayashi, Yoshiyuki Suzuki, Fumitaka Suzuki, Kenji Ikeda, Hiromitsu Kumada
Publié 2021

The sex steroid precursor dehydroepiandrosterone prevents nonalcoholic steatohepatitis by activating the AMPK pathway mediated by GPR30

par Longlong Li, Hongjun Wang, Yao Yao, Ji Cao, Zhihao Jiang, Weiyuan Yan, Xu Chu, Qian Li, Miaomiao Lu, Haitian Ma
Publié 2021

Pathophysiological Molecular Mechanisms of Obesity: A Link between MAFLD and NASH with Cardiovascular Diseases

par Jorge Gutiérrez-Cuevas, Arturo Santos, Juan Armendariz-Borunda
Publié 2021